3 results
Approved WMOCompleted
To study the potential of baclofen as an anti-craving/relapse agent in GHB dependent patients.
Approved WMOCompleted
To assess the safety and tolerability of multiple doses of PQ912 compared with placebo in subjects with early stage of Alzheimers Disease.
Approved WMOCompleted
Primary Objective: To determine whether in recently diagnosed PMR patients concomitant treatment to glucocorticoids with MTX 25 mg/week compared to a placebo will lead to a higher proportion of GC-free remission at 52 weeks. Secondary Objectives: To…